Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Surveillance
Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response
Table 2
Program area | CDC headquarters | CDC Haiti office |
---|---|---|
Clinical case management |
OHRI enhanced by developing a COVID-19 module for case management and surveillance at healthcare facilities |
PEPFAR-funded HIV systems were used for healthcare facilities and community-based COVID-19 case management. |
Surveillance |
Enhanced national health information exchange model was used to link electronic systems for COVID-19 case confirmation and case management |
Existing interoperability solutions were leveraged for data sharing via a health information exchange across 2 national COVID-19 data hubs |
Laboratory |
Automated exchange functionality was developed for COVID-19 testing requests and results between EMR and local laboratory information systems directly at a facility or through a national data repository |
PEPFAR systems were replicated for COVID-19 surveillance, and a laboratory component was added for COVID-19 laboratory data flow |
Dashboard | Dashboard requirements were developed for specific indicators, such as the number of persons living with HIV who were hospitalized for COVID-19 | COVID-19 surveillance dashboard was built by leveraging the HIV dashboard used to track patient retention in HIV care |
*CDC, US Centers for Disease Control and Prevention; EMR, electronic medical record; OHRI, Open medical record system HIV reference implementation; PEPFAR, United States President’s Emergency Plan for AIDS Relief.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: September 03, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.